Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis is a research paper published in Arthritis Research & Therapy (2023). On theSindex it has a DataRank of 0.360. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R21-AR078339
NIAMS NIH HHS
Grant: P30 AR072577
NIAMS NIH HHS
Grant: R21 AR078339
NIAMS NIH HHS
Grant: R01 AR080193
National Institutes of Health
Grant: 5P30AR072577-05
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
National Institutes of Health
Grant: 1R21AR078339-01A1
Studying exceptional treatment non-responders and genetics to predict treatment response in rheumatoid arthritis
Harold and DuVal Bowen Fund
FWCI
1.49
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals